26-Mar-2024 | Zion Market Research
Zion Market Research has published a new report titled “Live Cell Imaging Market by Product (Consumables, Instruments, Services, and Software), by Application (Stem Cells, Cell Biology, and Drug Discovery), by Technology (Fluorescence Recovery After Photo Bleaching, Time Lapse Microscopy, High Content Screening, Fluorescence Resonance Energy Transfer, and Others), and by End-User (Biotechnology and Pharmaceutical Companies, Research Institutes, and Contract Research Organizations): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024–2032”. According to the report, global live cell imaging market was approximately USD 2.74 Billion in 2023 and is expected to generate around USD 6.00 Billion by 2032, at a CAGR of around 9.10% between 2024 and 2032.
Live cell imaging is the study of living cells using time lapse microscopy. The rising incidence of cancer, growing high content screening techniques use in drug discovery methods, faster diagnostic facilities, and increasing investments made in research funding has led to the growth of the global live cell imaging market. The development of new drugs and the growing use of high content screening has further propelled the global live imaging market worldwide. However, the shortage of skilled professionals and the high cost of high content screening may hinder the live cell imaging market. Alternatively, the use of live cell imaging in the field of personalized medicine is anticipated to offer new growth opportunities in the live cell imaging market over the forecast time period.
Browse the full “Live Cell Imaging Market by Product (Consumables, Instruments, Services, and Software), by Application (Stem Cells, Cell Biology, and Drug Discovery), by Technology (Fluorescence Recovery After Photo Bleaching, Time Lapse Microscopy, High Content Screening, Fluorescence Resonance Energy Transfer, and Others), and by End-User (Biotechnology and Pharmaceutical Companies, Research Institutes, and Contract Research Organizations): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024–2032” Report at https://www.zionmarketresearch.com/report/live-cell-imaging-market
Based on the product, the market includes consumables, instruments, services, and software. The instrument segment held the largest market share in 2024, due to the launch of new technologies, rising incidences of chronic diseases, and increment in government funding for stem cell-based research.
On the basis of application, the market is categorized into cell biology, stem cells, and drug discovery. The stem cell segment accounted for the largest share in 2024, owing to the increasing investments and research activities being conducted on stem cell research.
By technology, the market includes high content screening (HCS), time lapse microscopy, fluorescence resonance energy transfer (FRET), and fluorescence recovery after photo bleaching (FRAP). Due to the rise in applications of genetic targeting peptides, FRET dominated the market in 2024.
The end-user segment comprises biotechnology and pharmaceutical companies, research institutes, and contract research organizations. Increasing focus of various institutes on drug discovery research programs and rising investments made by the government to support scientific goals are driving the research institutes segment.
North America is expected to dominate the global live cell imaging market over the forecast time period, owing to the huge government investments for developing research facilities, rising number of drug development regulations, flourishing biotechnology and pharmaceutical industries, increasing cancer cases, and various advancements witnessed in live cell imaging techniques. The European live cell imaging market is another vital region globally, due to the increasing incidence of chronic diseases, cancer, neurodegenerative disorders, and CVDs. Various upcoming projects and generous funding by the UK government in cell and developmental biology have also favored the live cell imaging market.
Some key players of the global live cell imaging market include Danaher Corporation, Nikon Corporation, Olympus Corporation, GE Healthcare, Bruker Corporation, Thermo Fischer Scientific, Sartorius, Etaluma, BioTek instruments, Perkin Elmer, Carl Zeiss, cytoSMART Technologies, and NanoEnTek.
About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed